3002 studies found for:    "Prostatic Neoplasms"
Show Display Options
Rank Status Study
1 Active, not recruiting CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution
Conditions: Prostate Cancer;   Prostatic Cancer;   Prostate Neoplasms;   Prostatic Neoplasms;   Cancer of the Prostate
Intervention: Radiation: CyberKnife Stereotactic Radiosurgery
2 Active, not recruiting CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
Conditions: Prostate Cancer;   Prostatic Cancer;   Prostatic Neoplasms;   Prostate Neoplasms;   Cancer of the Prostate
Intervention: Radiation: CyberKnife Stereotactic Radiosurgery
3 Recruiting Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer
Conditions: Prostate Cancer;   Prostatic Cancer;   Prostate Neoplasms;   Prostatic Neoplasms;   Cancer of the Prostate
Intervention: Radiation: CyberKnife Stereotactic Radiosurgery
4 Terminated Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostate Cancer;   Castration Resistant Prostate Cancer;   Prostatic Neoplasms
Interventions: Drug: cabozantinib;   Drug: abiraterone;   Drug: prednisone
5 Completed A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer
Conditions: Prostate Cancer;   Prostatic Neoplasms;   Cancer of the Prostate
Intervention: Drug: IPI-504
6 Terminated Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Castration Resistant Prostate Cancer;   Pain;   Prostatic Neoplasms
Interventions: Drug: cabozantinib;   Drug: mitoxantrone;   Drug: prednisone
7 Completed Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Conditions: Prostate Cancer;   Castration Resistant Prostate Cancer;   Pain;   Prostatic Neoplasms
Interventions: Drug: cabozantinib;   Drug: prednisone
8 Recruiting A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostatic Neoplasms;   Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Interventions: Drug: Abiraterone Acetate;   Drug: Prednisone;   Drug: JNJ-56021927
9 Completed
Has Results
An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy
Conditions: Prostatic Neoplasms;   Prostate Cancer
Interventions: Drug: Abiraterone acetate;   Drug: Prednisone
10 Unknown  Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression
Conditions: Prostatic Neoplasms;   Low Grade Prostate Cancer
Interventions: Other: Dietary intervention first;   Drug: Drug (Dutasteride) intervention first
11 Active, not recruiting MR Image Guided Therapy in Prostate Cancer
Conditions: Prostate Cancer;   Prostatic Neoplasms
Intervention: Device: Visualase Thermal Therapy System
12 Completed Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Conditions: Prostatic Neoplasm;   Prostate Cancer;   Prostatic Adenocarcinoma
Interventions: Biological: sipuleucel-T;   Drug: leuprolide acetate
13 Terminated Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Prostatic Neoplasms
Intervention: Drug: Cabazitaxel plus bavituximab
14 Recruiting Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Androgen-independent Prostate Cancer;   Recurrent Prostate Cancer
Interventions: Drug: onapristone;   Drug: abiraterone
15 Completed Study of Prostate Cancer in Black and White U.S. Veterans
Conditions: Prostate Cancer;   Prostatic Neoplasms
Intervention:
16 Recruiting Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms
Condition: Prostatic Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
17 Terminated
Has Results
Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy
Conditions: Prostate Cancer;   Prostatic Neoplasms;   Castrate-resistant Prostate Cancer (CRPC);   Androgen-insensitive Prostate Cancer;   Hormone-refractory Prostate Cancer;   Metastatic Disease
Intervention: Drug: Itraconazole
18 Terminated
Has Results
Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Prostatic Neoplasms;   Castrate-resistant Prostate Cancer (CRPC);   Androgen-insensitive Prostate Cancer;   Hormone-refractory Prostate Cancer;   Metastatic Disease
Interventions: Drug: Temsirolimus;   Drug: Casodex (bicalutamide)
19 Completed Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene Expression
Conditions: Prostatic Neoplasms;   Prostate Cancer
Intervention: Dietary Supplement: Selenium
20 Recruiting Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
Conditions: Prostatic Neoplasms;   Prostate Cancer
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years